Ferroptosis: Final destination for cancer?

Cell Prolif. 2020 Mar;53(3):e12761. doi: 10.1111/cpr.12761. Epub 2020 Feb 25.

Abstract

Ferroptosis is a recently defined, non-apoptotic, regulated cell death (RCD) process that comprises abnormal metabolism of cellular lipid oxides catalysed by iron ions or iron-containing enzymes. In this process, a variety of inducers destroy the cell redox balance and produce a large number of lipid peroxidation products, eventually triggering cell death. However, in terms of morphology, biochemistry and genetics, ferroptosis is quite different from apoptosis, necrosis, autophagy-dependent cell death and other RCD processes. A growing number of studies suggest that the relationship between ferroptosis and cancer is extremely complicated and that ferroptosis promises to be a novel approach for the cancer treatment. This article primarily focuses on the mechanism of ferroptosis and discusses the potential application of ferroptosis in cancer therapy.

Keywords: GPx4; cancer therapy; ferroptosis; lipid peroxidation.

Publication types

  • Review

MeSH terms

  • Animals
  • Ferroptosis*
  • Glutathione / metabolism
  • Humans
  • Iron / metabolism
  • Lipid Peroxidation*
  • Neoplasms / metabolism*
  • Neoplasms / pathology
  • Neoplasms / therapy
  • Peroxides / metabolism*
  • Phospholipid Hydroperoxide Glutathione Peroxidase / metabolism
  • Proto-Oncogene Proteins p21(ras) / metabolism
  • Tumor Suppressor Protein p53 / metabolism

Substances

  • Peroxides
  • Tumor Suppressor Protein p53
  • Iron
  • Phospholipid Hydroperoxide Glutathione Peroxidase
  • Proto-Oncogene Proteins p21(ras)
  • Glutathione